Editing Genetic disorder (section)

== Treatment ==
[[File:Personal_genomics_gene_therapy_flowchart.png|right|thumb|177x177px|From [[personal genomics]] to gene therapy]]
{{See also|Gene therapy}}
The treatment of disorder an ongoing battle, with over 1,800 [[gene therapy]] clinical trials having been completed, are ongoing, or have been approved worldwide.<ref>{{Citation |title=Part Three: The Pro-Acta Sessions |date=2017-12-03 |work=Early Sessions of the Synod of Dordt |pages=1–262 |url=https://doi.org/10.13109/9783666570544.1 |access-date=2025-01-08 |place=Göttingen |publisher=Vandenhoeck & Ruprecht |isbn=978-3-525-57054-8}}</ref><ref>{{cite journal | vauthors = Ginn SL, Alexander IE, Edelstein ML, Abedi MR, Wixon J | title = Gene therapy clinical trials worldwide to 2012 - an update | journal = The Journal of Gene Medicine | volume = 15 | issue = 2 | pages = 65–77 | date = February 2013 | pmid = 23355455 | doi = 10.1002/jgm.2698 | s2cid = 37123019 }}</ref> Despite this, most treatment options revolve around treating the symptoms of the disorders in an attempt to improve patient quality of life. 

Gene therapy refers to a form of treatment where a healthy gene is introduced to a patient. This should alleviate the defect caused by a faulty gene or slow the progression of the disease. A major obstacle has been the delivery of genes to the appropriate cell, tissue, and organ affected by the disorder. Researchers have investigated how they can introduce a gene into the potentially trillions of cells that carry the defective copy. Finding an answer to this has been a roadblock between understanding the genetic disorder and correcting the genetic disorder.<ref>{{cite journal | vauthors = Verma IM | title = Medicine. Gene therapy that works | journal = Science | volume = 341 | issue = 6148 | pages = 853–855 | date = August 2013 | pmid = 23970689 | doi = 10.1126/science.1242551 | bibcode = 2013Sci...341..853V | s2cid = 206550787 }}</ref>